APRIL was shown to protect against atherosclerosis by binding to heparin-sulphate proteoglycans in mice, and decreased serum levels are associated with long-term cardiovascular mortality in individuals with atherosclerosis53. The gene discussed is TNFSF13; the disease is atherosclerosis.